ArticleFrontiers in cardiovascular medicine2025

Reduced plasma levels of neuregulin-1 are associated with adverse outcomes in patients with atherosclerotic cardiovascular disease.

Jie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.